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Peripheral CD103+ dendritic cells form
a unified subset developmentally related
to CD8+ conventional dendritic cells
Brian T. Edelson,1 Wumesh KC,1 Richard Juang,1 Masako Kohyama,1,2
Loralyn A. Benoit,3 Paul A. Klekotka,4 Clara Moon,1 Jörn C. Albring,1,2
Wataru Ise,1,2 Drew G. Michael,1 Deepta Bhattacharya,1
Thaddeus S. Stappenbeck,1 Michael J. Holtzman,3,5 Sun-Sang J. Sung,6
Theresa L. Murphy,1 Kai Hildner,1,2 and Kenneth M. Murphy1,2

Although CD103-expressing dendritic cells (DCs) are widely present in nonlymphoid tissues,
the transcription factors controlling their development and their relationship to other DC
subsets remain unclear. Mice lacking the transcription factor Batf3 have a defect in the
development of CD8+ conventional DCs (cDCs) within lymphoid tissues. We demonstrate
that Batf3/ mice also lack CD103+CD11b DCs in the lung, intestine, mesenteric lymph
nodes (MLNs), dermis, and skin-draining lymph nodes. Notably, Batf3/ mice displayed
reduced priming of CD8 T cells after pulmonary Sendai virus infection, with increased
pulmonary inflammation. In the MLNs and intestine, Batf3 deficiency resulted in the
specific lack of CD103+CD11b DCs, with the population of CD103+CD11b+ DCs remaining
intact. Batf3/ mice showed no evidence of spontaneous gastrointestinal inflammation
and had a normal contact hypersensitivity (CHS) response, despite previous suggestions
that CD103+ DCs were required for immune homeostasis in the gut and CHS. The
relationship between CD8+ cDCs and nonlymphoid CD103+ DCs implied by their shared
dependence on Batf3 was further supported by similar patterns of gene expression and
their shared developmental dependence on the transcription factor Irf8. These data
provide evidence for a developmental relationship between lymphoid organ–resident
CD8+ cDCs and nonlymphoid CD103+ DCs.
CORRESPONDENCE
Kenneth M. Murphy:
kmurphy@wustl.edu
Abbreviations used: cDC, conventional DC; CDP, common
DC precursor; CHS, contact
hypersensitivity; DNFB,
1-fluoro-2,4-dinitrobenzene;
DP, double positive; DSS,
dextran sodium sulfate; LC,
Langerhans cell; LP, lamina
propria; MLN, mesenteric
lymph node; pDC, plasmacytoid
DC; SDLN, skin-draining
lymph node; SeV, Sendai virus.

DCs comprise a heterogeneous group of APCs
found throughout the body that include plasmacytoid DCs (pDCs) and CD11chigh conventional DCs (cDCs). Mouse cDCs in lymphoid
organs include CD8+ and CD8 subsets that
have distinct functional properties (Steinman,
2007; Naik, 2008). DC populations present in
nonlymphoid organs also include several unique
DC subsets. Although there has been some
progress in defining the phenotypic properties of DCs in the lung, gastrointestinal tract,

and skin, the relationship between peripheral
DCs and lymphoid-resident DCs is unclear
(GeurtsvanKessel and Lambrecht, 2008; Kelsall,
2008; Udey and Nagao, 2008). In these tissues,
CD103+ DCs have been identified that generally share the phenotype CD103+CD11blow/
DEC205+, and in the lung and skin also express the lectin Langerin. These CD103+ subsets appear to represent migratory cells of
similar phenotype and are identified in lymph
nodes draining these tissues. In some studies,
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RESULTS
Batf3/ mice lack lung CD103+ DCs
The mouse lung and associated airways are known to contain two distinct CD11c+ DC subsets (CD103+CD11b
and CD103CD11b+) in addition to highly autofluorescent
CD11c+CD103CD11b macrophages (GeurtsvanKessel and
Lambrecht, 2008). We performed flow cytometry on cell
suspensions of perfused, digested lungs from Batf3+/+ (WT)
and Batf3/ mice (Fig. 1 A). After gating on CD45+CD11c+
cells (a mixture of DCs and macrophages), DCs were identified in the autofluorescentlow fraction and subdivided by
CD103 and CD11b expression. Lungs from WT 129S6/
SvEv mice contain the two typical DC subsets in addition to
a third CD103+CD11b+ (double-positive [DP]) population.
This DP population has not been described previously but
was consistently present in the control 129S6/SvEv mice
used in analyzing Batf3/ mice. Strikingly, 129S6/SvEv
background Batf3/ mice lacked both CD103+CD11b and
DP lung DCs but had normal numbers of CD103CD11b+
lung DCs (Fig. 1, A and B). CD103+ lung DCs from WT
824

mice expressed Langerin by intracellular staining. In contrast,
DCs from Batf3/ lungs showed no Langerin expression in
any population. These results indicate that Batf3/ mice lack
the CD103+ Langerin+ population of lung DCs rather than
simply lacking expression of a single marker (Fig. 1 C).
Finally, the loss of this CD103+ population was caused by a
cell-intrinsic defect, because in mixed BM chimeras, donorderived Batf3/ lung DCs selectively lacked this population
despite the normal development of CD103+ lung DCs from
cotransferred WT BM (Fig. S1 A).
To analyze the role for lung CD103+ DCs in a viral
pathogen model, we infected WT and Batf3/ mice intranasally with SeV (Fig. 1, D and E; and Fig. S2). On day 8
after infection, Batf3/ mice showed markedly decreased
numbers of SeV-specific T cells, as measured by Kb-SeV
NP 324–332 MHC pentamer staining (Cole et al., 1994). In
agreement with reduced priming of CD8 T cells, Batf3/
mice showed greater weight loss after infection and had
increased pulmonary inflammatory infiltrates on days 9 and
15 after infection.
Microarray expression analysis of lung DCs
Based on shared functional properties between classical CD8+
cDCs and lung CD103+ DCs (Sung et al., 2006; del Rio et al.,
2007; Kim and Braciale, 2009), and their shared developmental requirement for Batf3, we next examined the transcriptional profiles of lung and splenic cDC subsets by expression
microarray analysis (Sung et al., 2006; Dudziak et al., 2007).
Specifically, we compared purified CD103+CD11b and
CD103CD11b+ lung DCs with splenic DEC205+ (surrogates for CD8+) or 33D1+ (surrogates for CD8) cDCs.
We compared the expression of transcription factors and
receptors that are selectively expressed by subsets of splenic
cDCs with their expression in subsets of lung DCs (Fig. 2, A
and B). Batf3, which is highly expressed in both CD8+ and
CD8 cDCs (Hildner et al., 2008), was also highly expressed in both lung DC populations (Fig. 2 A). Irf8 and Id2
(Hacker et al., 2003; Kusunoki et al., 2003), which are
required for CD8+ cDC development, are selectively expressed in the CD103+ subset of lung DCs. In a corresponding
manner, Irf4, which is required for development of CD8
splenic cDCs, is selectively expressed in the CD11b+ subset
of lung DCs. Relb, reported to be required for development
of CD8 cDC, (Wu et al., 1998), in contrast, was not
differentially expressed between lung DC subsets.
Several surface markers also showed a correspondence
between splenic and lung DC subsets. Itgae (CD103) and
Cd207 (Langerin) were highly expressed in lung CD103+
DCs and also showed significant expression in CD8+ splenic
cDCs. Likewise, CD24a and Ly75 (DEC205) also show a
similar correspondence (Fig. 2 B). Several other receptors
were selectively expressed more highly in CD11b+ lung DCs
and splenic CD8 cDCs than in CD103+ lung DCs or
CD8+ cDCs, including Itgam (CD11b), Emr1 (F4/80), and
Sirpa (CD172a). In contrast, Cd8a and Cd4, which are useful
for the discrimination of splenic cDCs, were not significantly
Revealing relationships between DC subsets | Edelson et al.
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peripheral CD103+ DCs have exhibited the specialized features
of TLR3 responsiveness and the capacity for cross-presentation,
suggesting a relationship with classical CD8+ DCs in lymphoid tissues, which themselves are CD103+CD11blow/neg
DEC205+Langerinlow (Sung et al., 2006; del Rio et al., 2007;
Bedoui et al., 2009).
We recently identified the transcription factor Batf3 as
being highly expressed in cDCs and selectively required
for the development of CD8+ DCs of lymphoid tissues.
Batf3/ mice had selective defects in generating CD8+
T cell responses to a virus, cross-presentation, and rejection
of syngeneic fibrosarcomas (Hildner et al., 2008). Batf3/
mice also had reduced numbers of CD103+CD8 cDCs in
skin-draining lymph nodes (SDLNs; Hildner et al., 2008), a
recently identified subset of peripheral cDCs (Bursch et al.,
2007; Ginhoux et al., 2007; Poulin et al., 2007). Because the
developmental stages of DCs are still incompletely defined,
the relationships between peripheral and lymphoid subsets
of cDCs are unclear. Other transcription factors have been
identified as important in the development of DCs (Merad
and Manz, 2009). In particular, Irf8 mutant and Irf8-deficient
mice also lack CD8+ cDCs but have additional immune
defects (Holtschke et al., 1996; Aliberti et al., 2003; Tsujimura
et al., 2003; Turcotte et al., 2005; Gabriele and Ozato, 2007;
Tailor et al., 2008).
In this study, we extend our analysis of the roles of the
transcription factors Batf3 and Irf8 in the development of
lymphoid and nonlymphoid cDCs in mice. We determine
that classical CD8+ cDCs and CD103-expressing DCs present in diverse nonlymphoid tissues appear developmentally
related based on similar requirements for both Batf3 and Irf8
and similar patterns of gene expression. Further, we use
Batf3/ mice to examine the role of CD103+ DCs in Sendai
virus (SeV) infection of the lung, intestinal homeostasis, and
skin-based contact hypersensitivity (CHS).
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expressed in lung DCs. Lastly, we examined the expression
of the growth factor receptors Flt3 (the receptor for the DC
growth factor Flt3L) and Csf1r (the receptor for M-CSF).

Flt3 transcript was most abundant in both splenic subsets and
in lung CD103+ cells, whereas Csf1r showed highest expression in lung CD11b+ cells (Fig. 2 C).

Downloaded from jem.rupress.org on September 13, 2011

Figure 1. Batf3/ mice lack lung CD103+ DCs. (A) Cell suspensions of lung digests from Batf3+/+ and Batf3/ mice were stained for CD45, CD11c,
autofluorescence (FITC channel; auto), CD11b, and CD103. Live CD45+CD11c+ cells, representing a mixture of lung macrophages and DCs, were initially
gated (left), with the low autofluorescent population (DCs) further analyzed for the discrimination of three pulmonary DC subsets (right). Numbers represent the percentage of cells within the indicated gates. (B) Numbers of pulmonary DCs per mouse for each of the three pulmonary DC subsets as gated in A.
Data represent the combination of two separate experiments, with each point representing the pooled lung cells from an individual mouse. Horizontal
lines represent the mean cell number. (C) Cell suspensions of lung digests from Batf3+/+ and Batf3/ mice were stained for CD45, CD11c, CD11b, CD103,
and intracellular Langerin. Live CD45+CD11c+ cells, representing a mixture of lung macrophages and DCs, were initially gated (left). A further gate was
drawn to encompass all pulmonary DCs and exclude CD11bCD103 lung macrophages. These DCs were analyzed for the expression of CD103 and Langerin (right). Numbers represent the percentage of cells within the indicated gates. Staining was performed on two individual mice per group in one independent trial. (D) Batf3+/+ and Batf3/ mice were infected with 100 PFU SeV intranasally or left uninfected (three or four uninfected mice per genotype;
four infected mice per genotype). At day 8 after infection, SeV-specific CD8+ T cells were identified in cell suspensions of lung digests stained for CD19,
Mac3, CD8, and Kb-SeV NP 324–332 MHC pentamers. CD8+CD19Mac3 cells were gated. Numbers represent the percentage of SeV-specific CD8+
T cells. Data are representative of two separate experiments (one in which staining was performed at day 9 after infection). (E) Percentage of SeV-specific
CD8+ T cells in the lungs of uninfected or infected mice, as stained in D. Horizontal lines represent the mean percentage.
JEM VOL. 207, April 12, 2010

825

Published March 29, 2010

population of CD4+Foxp3+ T reg cells in both the LP and
MLNs (Fig. 3, C and D; and Fig. S3 D), with no evidence of
inflammatory bowel disease in either the small intestine or
colon (Fig. 3 E). In addition, CD4 and CD8 T cells from the
LP and MLNs of Batf3/ mice showed normal expression of
the gut-homing receptors 47 integrin and CCR9 (Fig. S4).
There was no difference in the sensitivity of Batf3/ and
WT mice to the dextran sodium sulfate (DSS) model of induced colitis (Fig. S5; Brown et al., 2007).
Batf3/ mice lack dermal CD103+ DCs
CD103+Langerin+ DCs have been recently described as a
unique, blood-derived migratory DC subset present in the
dermis of mouse skin, and have been shown to traffic to
SDLNs both in the steady state and during inflammation
(Bursch et al., 2007; Ginhoux et al., 2007; Poulin et al.,
2007). These cells are distinct from CD103Langerin+ Langerhans cells (LCs) of the epidermis and CD103Langerin

Figure 2. Comparative microarray expression analysis of lung and splenic DC subsets. Microarray data for two lung DC and two splenic cDC
subsets were normalized and modeled (three replicate arrays for each DC subset). Model-based expression indices were calculated using dChip software for selected (A) transcription factors, (B) surface receptors, and (C) growth factor receptors. Values represent the mean index, with error bars
representing the standard deviation.
826
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Batf3/ mice lack intestinal CD103+CD11b DCs
Several intestinal DC subsets have been described in mice
(Kelsall, 2008; Bogunovic et al., 2009; Varol et al., 2009).
CD103+ DCs of the lamina propria (LP) and mesenteric
lymph nodes (MLNs) have been shown in vitro to promote
the expression of specific integrins and chemokine receptors
on T cells, and to direct the differentiation of CD4+Foxp3+
T reg cells, and are thought to be important components of
intestinal homeostasis (Coombes and Powrie, 2008). Analysis
of the LP and MLNs showed the absence of CD103+CD11b
DCs in Batf3/ mice (Fig. 3, A and B; and Fig. S3, A–C),
whereas CD103+CD11b+ DCs remained present in these
mice. MLNs of Batf3/ mice were found to lack the classical
lymphoid organ–resident CD8+CD103low cDCs and the
LP-derived CD103+CD8low/ DCs (Fig. S3, A and B). Further characterization of these subsets from WT mice revealed
that only classical CD8+ cDCs express Langerin, whereas
both subsets express DEC205. Batf3/ mice had a normal
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CD103Langerin+ LCs, both known to express DEC205+
and lack expression of CD8 (Fig. 4, B and C). Batf3/
mice again demonstrated the complete absence of CD103+
dermal DCs, with a normal population of LCs. As we have
reported previously (Hildner et al., 2008), Batf3/ mice
also lacked LangerinlowCD8+ cDCs in their SDLNs (Fig. 4 B).
The loss of CD103+ dermal DCs in Batf3/ mice was caused
by a cell-intrinsic defect, based on analysis of mixed BM
chimeras (Fig. S1 B).
Irf8 mutant mice lack nonlymphoid CD103+ DCs
Irf8-deficient and BXH2 recombinant inbred mice, harboring a point mutation in the Irf8 gene, lack classical CD8+
cDCs of the spleen (Aliberti et al., 2003; Tailor et al., 2008).
These strains also have other immune and hematopoietic
abnormalities because of the actions of Irf8 in other cell types

Figure 3. Batf3/ mice lack intestinal CD103+CD11b DCs. (A) Cell suspensions of LP from Batf3+/+ and Batf3/ mice were stained for CD11c,
I-Ab, CD11b, and CD103 (representative data from a single experiment involving two to three mice per group; two independent experiments were performed). Live CD11chighI-Ab+ cells were gated. Numbers represent the percentage of cells within the indicated gates. (B) Percentage of CD103+CD11b
LP DCs as gated in A. Horizontal lines represent the mean percentage. (C) Cell suspensions of LP from Batf3+/+ and Batf3/ mice were stained for CD3e,
CD4, CD8, and intracellular Foxp3 (representative data from a single experiment with three mice per group). Live CD3e+CD4+CD8 T cells were gated.
Numbers represent the percentage of cells within the indicated gates. (D) Percentage of Foxp3+ LP T cells as gated in C. Horizontal lines represent the
mean percentage. (D) Light microscopy of H&E-stained sections of the small intestine and colon from Batf3+/+ and Batf3/ mice (data are representative
of a single experiment involving two mice per group at 8–10 mo of age; a separate trial examined five mice per group at 3 mo of age with similar
findings). Note the normal villous architecture and LP leukocytes, without evidence of inflammation. Bars: (left and right) 100 µm; (middle) 500 µm.
JEM VOL. 207, April 12, 2010
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dermal DCs (Merad et al., 2008). Migratory LCs themselves
are also present in the dermis of mice but are thought to represent cells trafficking toward SDLNs. We performed flow
cytometry on cell suspensions prepared from the epidermis
and dermis of WT and Batf3/ mice, and gated on DCs
based on their expression of CD45 and CD11c (Fig. 4 A).
Epidermal LCs were present normally in Batf3-deficient
skin, whereas dermal preparations from these mice showed
the absence of a small but distinct population of CD103+
Langerin+ dermal DCs. Gating on all Langerin-expressing
cells in each preparation showed the normal presence of
epidermal and dermal CD103CD11b+ LCs in WT and
Batf3/ mice, whereas the latter mice clearly lacked the
dermal CD103+CD11blow/ DC subset.
We next assessed SDLNs from WT and Batf3-deficient
mice for the presence of CD103+Langerin+ dermal DCs and

Published March 29, 2010
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Figure 4. Batf3/ mice lack dermal CD103+ DCs. (A) Cell suspensions of epidermal and dermal digests from Batf3+/+ and Batf3/ mice were
stained for CD45, CD11c, intracellular Langerin, CD103, and CD11b (representative data from a single experiment involving two mice per group). Live
CD45+CD11c+ cells were initially gated (left), allowing for the discrimination of CD103Langerin+ LCs and CD103+Langerin+ dermal DCs. Langerin-expressing cells were gated for further analysis (right), allowing good discrimination of these two populations based on their differential expression of CD11b.
Numbers represent the percentage of cells within the indicated gates. (B) Cell suspensions of pooled SDLNs from Batf3+/+ and Batf3/ mice were stained
for CD11c, intracellular Langerin, CD103, DEC205, CD11b, and CD8 (representative data from a single experiment involving two mice per group; experiments with similar combinations of stains have been performed in two other independent trials involving at least one mouse per genotype in each trial).
Live CD11chigh cells were gated. Note the complete absence of CD103+Langerin+ dermal DCs (far left) and CD8+Langerinlow lymph node–resident DCs in
Batf3/ mice. Langerin-expressing cells present in Batf3/ mice represent epidermal LCs. (C) Percentage and number of DCs per inguinal lymph node
for three DC subsets. In this case, individual cell suspensions of inguinal lymph nodes (three mice per group, six lymph nodes total) were stained for
CD11c, DEC205, CD8, CD103, and intracellular Langerin. Live CD11chigh cells were initially gated. Lymph node–resident DEC205+CD8+ cDCs were identified as a percentage of this gate. Migratory DCs were further gated as DEC205+CD8 cells, and Langerin+CD103+ dermal DCs and Langerin+CD103 LCs
were identified as percentages of this gate. Horizontal lines represent the mean percentage and cell number.
828
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These findings show that nonlymphoid CD103+ DCs and
CD8+ splenic cDCs share a developmental dependence on
both Irf8 and Batf3.
Batf3/ mice display a normal CHS response
CHS is an inflammatory reaction of the skin mediated by
hapten-specific T cells (Gocinski and Tigelaar, 1990). Several studies have examined the role of epidermal LCs in
the CHS response (Bennett et al., 2005; Kaplan et al., 2005;
Kissenpfennig et al., 2005). Each of these groups used a different mouse model lacking LCs, and each came to a different conclusion regarding the role of this DC subset in CHS.
Two of these models used a diphtheria toxin receptor–based
conditional depletion strategy to eliminate Langerin-expressing
cells. However, it is now known that diphtheria toxin can
deplete CD103+Langerin+ dermal DCs in addition to epidermal

Figure 5. Irf8 mutant mice lack nonlymphoid CD103+ DCs. (A) Cell suspensions of spleens from WT (B6C3HF1/J) and Irf8 mutant (BXH2) mice were
stained for CD11c, CD11b, CD8, and DEC205 (representative data from a single experiment involving two mice per group; a second independent experiment was performed with one mouse per group). Live CD11chigh cells were gated. Numbers represent the percentage of cells within the indicated gates.
(B) Cell suspensions of lung digests from WT (B6C3HF1/J) and Irf8 mutant (BXH2) mice were stained for CD45, CD11c, CD11b, and CD103 (representative
data from a single experiment involving two mice per group; two independent experiments were performed; a second independent experiment was performed with one mouse per group). Live CD45+CD11c+ cells, representing a mixture of lung macrophages and DCs, were gated. Numbers represent the
percentage of cells within the indicated gates. (C) Cell suspensions of LP from WT (C57BL/6) and Irf8 mutant (BXH2) mice were stained for CD11c, CD11b,
and CD103 (representative data from a single experiment involving two mice per group; a second independent experiment was performed with one
mouse per group). Live CD11chigh cells were gated. Numbers represent the percentage of cells within the indicated gates. (D) Cell suspensions of pooled
SDLNs from WT (B6C3HF1/J) and Irf8 mutant (BXH2) mice were stained for CD11c, CD8, DEC205, CD11b, and CD103 (representative data from a single
experiment involving two mice per group; a second independent experiment was performed with one mouse per group). Live CD11chigh cells were initially
gated (left) to allow the identification of lymph node–resident DEC205+CD8+ cDCs. Migratory DCs were further gated as DEC205+CD8 cells and
analyzed for their expression of CD11b and CD103. Numbers represent the percentage of cells within the indicated gates.
JEM VOL. 207, April 12, 2010
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and the presence of a replication-competent endogenous
mouse leukemia virus in BXH2 mice (Holtschke et al., 1996;
Turcotte et al., 2005; Turcotte et al., 2007). However, in the
cDC compartment of both strains, there is a selective absence
of CD8+ DCs in vivo and the CD8+ surrogate population
in Flt3L-derived BM cultures in vitro. Because of overlapping effects of Irf8 and Batf3 deficiency, and high expression
of Irf8 in CD103+ lung DCs (Fig. 2 A), we hypothesized
that Irf8 mutant BXH2 mice would also lack development of
nonlymphoid CD103+ DCs. Irf8 mutant mice lacked CD8+
splenic cDCs (Fig. 5 A), consistent with an earlier report
(Tailor et al., 2008). As we predicted, we found that Irf8
mutant mice lacked CD103+CD11b lung DCs (Fig. 5 B).
In addition, Irf8 mutant mice lacked LP CD103+CD11b
DCs (Fig. 5 C) and lacked both DEC205+CD8+ cDCs and
CD103+DEC205+CD8 dermal DCs in SDLNs (Fig. 5 D).

Published March 29, 2010

DCs in CHS. Histological examination of the ears on day 2
after elicitation showed significant edema and leukocyte infiltration in both WT and Batf3/ mice (Fig. 6 B). To rule out
the possibility that our CHS protocol may have overlooked a
role for CD103+ dermal DCs caused by the dose and schedule of sensitization and elicitation, we performed a separate
experiment in which three different protocols for DNFBbased CHS were used (Fig. S6). In each case, Batf3/ mice
displayed normal hapten-specific ear swelling in sensitized
mice. In summary, our results together with previous studies
indicate that epidermal LCs are sufficient to support CHS
responses in the absence of CD103+ dermal DCs.
DISCUSSION
CD103+ DCs constitute a unified DC subset
We present evidence for a common developmental pathway
for peripheral CD103+ DCs in lung, gut, and skin- and lymphoid organ–resident CD8+ cDCs. Conceivably, all peripheral CD103+ and lymphoid organ–resident CD8+ cDCs

Figure 6. Batf3/ mice display a normal CHS response. (A) Sensitized and nonsensitized Batf3+/+ and Batf3/ mice were treated on their ears
with DNFB to elicit a hapten-specific CHS response. Ear swelling was measured at days 1 and 2 after elicitation. Each point represents an individual ear
(three mice per group, six ears per group; Fig. S6 A shows an independent trial of this same protocol). Horizontal lines represent the mean. (B) Light microscopy of H&E-stained sections of treated ears from nonsensitized and sensitized Batf3+/+ and Batf3/ mice. Sensitized ears demonstrate edema and
focal areas of leukocyte infiltration (arrowheads) composed largely of PMNs. Bars: (left) 1 mm; (right) 100 µm.
830
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LCs in these mice (Bursch et al., 2007; Ginhoux et al., 2007;
Poulin et al., 2007). Appropriate timing of diphtheria toxin
treatment can allow for depletion of both Langerin-expressing
cell types or the selective depletion of LCs (Bursch et al.,
2007; Wang et al., 2008). Using this approach, CHS responses
were found to be diminished upon depletion of both epidermal LCs and dermal CD103+ DCs, but were normal upon
depletion of only epidermal LCs (Bursch et al., 2007; Wang
et al., 2008). By inference, these studies suggested that that
dermal CD103+ DCs were sufficient for mediating CHS.
Because this conclusion was based on indirect evidence, we
wished to test whether CHS responses were normal in Batf3deficient mice, which lack CD103+ dermal DCs but have
normal epidermal LCs.
Mice were sensitized with 0.5% 1-fluoro-2,4-dinitro
benzene (DNFB) on their abdomens 5 and 4 d before the elici
tation of an ear-swelling response (Fig. 6 A). Batf3/ mice
displayed normal hapten-specific ear swelling in sensitized
mice, suggesting no absolute requirement for CD103+ dermal
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monocytes and trace their differentiation into lung DCs.
However, no monocyte transfer experiments were performed.
It is not clear at this time whether lung CD103+ DCs represent a special class of CD103+ DCs that may arise from blood
monocytes, or whether the manipulations used resulted in additional pathways besides those operating in the steady state.
Because Flt3 is expressed on CDPs and splenic cDCs but not
blood monocytes (Kingston et al., 2009), it would be unexpected for monocytes to be the circulating precursor for
CD103+ lung DCs, which themselves express high levels of
Flt3 (Fig. 2 C). On the other hand, lung CD11b+ DCs and
monocytes both express Csf1r (Fig. 2 C; Kingston et al., 2009),
consistent with their developmental relationship.
Functions of peripheral CD103+ DCs
CD103+ DCs have been identified in individual anatomical
locations. In the lung, CD103+ DCs were notable for their
response to TLR3 stimulation and their ability to cross-present
antigen to CD8+ T cells (Sung et al., 2006; del Rio et al.,
2007). Our microarray analysis confirms selective expression
of Tlr3 on lung CD103+ DCs and splenic CD8+ cDCs.
Some studies have suggested that lung CD103+ DCs preferentially prime CD8+ T responses to respiratory influenza infection (GeurtsvanKessel et al., 2008; Kim and Braciale,
2009). One study made use of Langerin–diphtheria toxin
receptor mice for the selective depletion of Langerin+CD103+
lung DCs (GeurtsvanKessel et al., 2008), finding reduced
viral clearance and virus-specific CD8+ T cell priming in
their absence (GeurtsvanKessel et al., 2008). A second study
examined the differential capacity of lung DC subsets to
prime CTLs and cross-present antigens ex vivo (Kim and
Braciale, 2009). In agreement, our results now show that
CD8 T cell responses to SeV are reduced in the absence of
pulmonary CD103+ DCs. In contrast, a recent report has
claimed that CD103CD11bhigh DCs of the lung were the
dominant cell presenting antigen to CD8 T cells during influenza infection based on ex vivo analysis of their presentation capacity at the peak of infection, although both lung DC
subsets presented antigen during early infection (Ballesteros-Tato
et al., 2010). Further, CD70, which is selectively expressed
by CD103CD11bhigh DCs, was important for the expansion
of influenza-specific CD8 T cells, but no direct assessment of
the requirement for CD103+ DCs for in vivo CD8 T cell
responses to influenza was made. Infection of Batf3/ mice
with influenza would help resolve this issue.
CD103+ DCs of the gut have been shown to exist in both
mouse and human (Jaensson et al., 2008). Initial interest in
this subset of gut DCs came after the observation that host
CD103 expression on a non–T or –B cell population was
important for the ability of T reg cells to ameliorate disease in
a T cell transfer model of colitis (a model of inflammatory
bowel disease induced by the transfer of CD4+CD45RBhigh
T cells into severe combined immunodeficiency or Ragdeficient recipients; Annacker et al., 2005). Because a subset
of gut DCs was the main cell type in these immunodeficient
recipients expressing CD103, these authors set out to characterize
831

Downloaded from jem.rupress.org on September 13, 2011

constitute a single branch of cDC development sharing a
common developmental precursor, developmental pathway,
and overall function. Several papers over the last few years
have collectively reported a pathway whereby BM common
myeloid progenitors give rise to macrophage and DC precursors, which give rise to common DC precursors (CDPs; Fogg
et al., 2006; Naik et al., 2007; Onai et al., 2007; Auffray et al.,
2009a; Liu et al., 2009). In transfer experiments, CDPs are
committed to give rise to pDCs, CD8+ cDCs, and CD8
cDCs. In the BM, spleen, and blood, an intermediate cell,
the pre-cDC, has been identified that gives rise only to cDC
subsets but not pDCs (Liu et al., 2009). In contrast, blood
monocytes are not precursors for splenic cDCs or pDCs, but
in some settings may generate inflammatory DCs, epidermal
LCs, and lung and gut CD11b+ DCs (León and Ardavin,
2008; Auffray et al., 2009b; Bogunovic et al., 2009; Varol et al.,
2009). Based on these studies and our results, we suggest that
pre-cDCs may also be blood-circulating precursors for CD103+
DCs in peripheral tissues.
During the review of our manuscript, a separate report
also identified the developmental relationship between peripheral CD103+ DCs and lymphoid organ–resident CD8+
cDCs (Ginhoux et al., 2009). As in our experiments, Irf8 was
found necessary for peripheral CD103+ DC development,
but Batf3 was not examined. In addition, Id2 was required, in
agreement with this factor’s role in CD8+ cDC development (Hacker et al., 2003) and its higher expression in
CD103+ DCs (Fig. 2 A). Using cell transfers, it was confirmed
that pre-cDCs were in fact circulating precursors of peripheral tissue CD103+ DCs. In Batf3/ mice, we find that the
number of pre-cDCs is normal (Fig. S7, A–C).
Gene expression data (Fig. 2 and Fig. S7 D) suggest a
model in which Irf8 and Batf3 cooperate functionally to
allow development of both lymphoid organ–resident CD8+
cDCs and peripheral tissue CD103+CD11b DCs. These
two subsets share many features, including patterns of gene
expression and their role in priming CD8 T cell responses.
Irf8 is expressed early, beginning at the CDP, and remains
highly expressed in the pre-cDC and in terminally differentiated CD8+ and peripheral CD103+ DC subsets. Importantly,
its expression is extinguished in lymphoid organ–resident
CD8 cDCs, which also derive from the CDP/pre-cDC.
In contrast, Batf3 becomes expressed only in the terminal
stages of DC development, being highly expressed by both
subsets of lymphoid organ–resident DCs and both subsets of
peripheral DCs. However, the overlap of high Irf8 and Batf3
expression is only found within the CD8+ and CD103+
subsets, suggesting cooperative interactions in their effects on
functional development.
One report that is inconsistent with the hypothesis that
pre-cDCs are the precursor for peripheral CD103+ DCs found
that Ly6Chi monocytes may be the precursor for CD103+
lung DCs (Jakubzick et al., 2008). This study was based on the
correlation of relative frequencies of blood Ly6Chigh and
Ly6Clow monocytes with lung CD103+ and CD11b+ DCs,
and used injected latex beads to identify blood-derived Ly6Chigh
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after DNA vaccination (Nagao et al., 2009), to be sufficient in
the absence of LCs to support epicutaneous immunization to
a foreign protein antigen, and to be efficient cross-presenting
APCs for both viral and skin-derived self antigens (Wang et al.,
2008; Bedoui et al., 2009). It will be important to examine
these responses in Batf3/ and Irf8/ or Irf8 mutant mice.
Previous studies indicated that CD103+ dermal DCs can
support a normal CHS response in the absence of LCs, but
that CHS was abrogated in the absence of both cell types
(Bursch et al., 2007; Wang et al., 2008). Our data using
Batf3/ mice represent the first CHS experiments in which
CD103+ dermal DCs were selectively eliminated in the presence of a normal LC population. We show no absolute requirement for this dermal DC subset in this response, and
suggest that LCs are sufficient in this regard. However, it is
possible that in the constitutive absence of CD103+ dermal
DCs in Batf3/ mice, other cells not normally involved in
CHS compensate for the loss of this subset.
Although Batf3 is highly expressed in lymphoid organ–
resident CD8+ and CD8 cDCs (Hildner et al., 2008), it
is not required for the development of the CD8 cDC
population. Likewise, Batf3 is expressed in both subsets of
lung DCs but is only required for the development of the
CD103+ subset. Thus, Batf3 is necessary but not sufficient for
the development of CD8+ lymphoid organ–resident and
CD103+ peripheral DC subsets. The transcription factors Irf8
and Id2, required for CD8+ cDC development (Hacker et al.,
2003; Kusunoki et al., 2003), are more selectively expressed
in CD8+ and CD103+ DC subsets but are also more widely
expressed in non-DC lineages compared with Batf3. Thus,
the development of DC subsets appears to be based on intersections of both subset- and lineage-specific expression of
transcription factors.
Our results reveal a developmental relationship between
peripheral CD103+ DCs present in diverse anatomical locations, as well as a shared developmental relationship between
these DCs and lymphoid organ–resident CD8+ cDCs. We
show that all of these DC subsets depend on both Batf3 and
Irf8 for their development. Numerous experimental systems
including diverse vaccination and immunization strategies,
and models of infection, transplantation, tumor immunity, and
autoimmunity have assigned important functions to CD8+
cDCs (Heath et al., 2004; López-Bravo and Ardavin, 2008).
Given that CD103+ DCs reside in virtually all peripheral
organs, their presence and activity should also be considered
in these models.
MATERIALS AND METHODS
Mice. WT 129S6/SvEv, C57BL/6, and B6.SJL mice were purchased from
Taconic. Batf3/ mice on a 129S6/SvEv background were previously generated in our laboratory (Hildner et al., 2008). Batf3/ mice were backcrossed six generations to the C57BL/6 background for use in mixed BM
chimera experiments. BXH2/TyJ (Irf8 mutant) mice, carrying a point mutation in exon 7 of Irf8 resulting in an Arg to Cys change at amino acid 294 of
the Irf8 protein (Turcotte et al., 2005), were purchased from the Jackson
Laboratory. These mice are a recombinant inbred strain between C57BL/6
and C3H/HeJ mice, and therefore B6C3HF1/J mice (The Jackson Laboratory)
Revealing relationships between DC subsets | Edelson et al.
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the function of this subset. These CD103+ DCs were reported
to migrate in the steady state from the LP to the MLNs, and
displayed the unique ability to induce the expression of the
gut-homing receptors CCR9 and 47 integrin on T cells in
vitro (Annacker et al., 2005; Johansson-Lindbom et al., 2005).
Subsequent work also highlighted the unique ability of
CD103+ DCs to induce the expression of the transcription
factor Foxp3 in CD4+ T cells in vitro, a marker of T reg cell
development (Coombes et al., 2007; Sun et al., 2007). CD103+
gut DCs were shown to selectively express genes necessary
for the production of TGF- and retinoic acid when they
were compared with CD103 gut DCs, and CD103+ DC
induction of Foxp3 expression was shown to be dependent on
both of these endogenously produced factors. More recently,
mice made deficient in all gut DCs (using a CD11c–diphtheria
toxin receptor transgenic system) and then reconstituted
with monocytes, allowing the selective repopulation of
CD103CD11b+ intestinal DCs, were found to be more susceptible to DSS-induced colitis, although no inflammation
was observed in the absence of DSS treatment (Bogunovic
et al., 2009; Varol et al., 2009). These data have led to the
hypothesis that gut CD103+ DCs are important for the maintenance of self-tolerance in the intestine (Coombes and
Powrie, 2008; Kelsall, 2008).
Our analysis of Batf3/ mice revealed the absence of
CD103+CD11b DCs in both the LP and MLNs, and yet
these mice displayed no evidence of spontaneous inflammation in their gastrointestinal tract and maintained a normal
population of T reg cells in their LP and MLNs. Several possibilities might explain the lack of predicted gut inflammation
in Batf3/ mice lacking CD103+ DCs. The presence of the
CD103+CD11b+ DP LP DC subset in these mice may be
sufficient to maintain homeostasis. In addition, other APCs
in the LP or MLNs may be able to generate T reg cells in the
gut. Indeed, LP macrophages, rather than CD103+ DCs,
were recently reported to induce CD4+ T cell expression of
Foxp3 in vitro (Denning et al., 2007). The LP of Batf3/
mice shows a normal population of macrophages. Thymically
derived T reg cells may be sufficient for intestinal homeostasis,
and we find no evidence of abnormal T reg cell development
in Batf3/ mice. Finally, Batf3/ mice also lack classical
CD8+ DCs in their MLNs, which may be required to prime
T cells responses against intestinal flora.
We show Batf3 and Irf8 to be transcription factors required
for the development of CD103+ dermal DCs. CD103+ dermal
DCs represent a distinct population of cells, sharing the expression of Langerin with epidermal LCs. These two cell types
have been recognized to differ in their radiosensitivity, their
repopulation kinetics after conditional depletion, and their developmental requirements for TGF- (Bursch et al., 2007;
Ginhoux et al., 2007; Poulin et al., 2007; Nagao et al., 2009).
Both Batf3/ and Irf8 mutant mice selectively lack this
skin-resident DC subset, in addition to their lack of lymphoid
organ–resident CD8+ cDCs, while maintaining a normal
epidermal LC population. CD103+ dermal DCs have been reported to play an important role in the presentation of antigen
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were used as WT controls for BXH2 mice in most experiments (although
in some cases C57BL/6 mice were used as controls). Experiments were generally performed with sex-matched mice at 6–12 wk of age. Mice were bred
and maintained in our specific pathogen–free animal facility according to
institutional guidelines with protocols approved by the Animal Studies
Committee of Washington University.

DC preparation and cell sorting. Lungs were perfused with 10 ml
DPBS via injection into the right ventricle after transection of the lower
aorta. Dissected lungs were minced and digested in 5 ml of Iscove’s modified Dulbecco’s media + 10% FCS (cIMDM) with 4 mg/ml collagenase D
(Roche) for 1 h at 37°C with stirring. EDTA (5-mM final concentration)
was added to cell suspensions, and cells were incubated on ice for 5 min.
Cells were passed through a 40-µm strainer before red blood cells lysis with
ACK lysis buffer. Cells were counted on an analyzer (Vi-CELL; Beckman
Coulter), and 2–3 × 106 cells were used per antibody staining reaction.
Spleens, MLNs, and SDLNs (typically pooled cervical, brachial, axillary,
and inguinal nodes, although in some cases inguinal nodes were analyzed separately) were digested in 5 ml cIMDM with 250 µg/ml collagenase B (Roche)
and 30 U/ml DNase I (Sigma-Aldrich) for 1 h at 37°C with stirring. EDTA
JEM VOL. 207, April 12, 2010

Mixed BM chimeras. BM cells from femurs and tibias were collected from
B6.SJL (CD45.1), C57BL/6 (CD45.2), and Batf3/ (CD45.2) mice (backcrossed six generations to the C57BL/6 background). Two mixtures of BM
cells were prepared at a 1:1 ratio: B6.SJL cells mixed with C57BL/6 cells, and
B6.SJL cells mixed with Batf3/ cells. 20 million total BM cells were transplanted by intravenous injection into B6.SJL mice that had received 1,200
rads of whole body irradiation on the day of transplant. Mixed chimeras were
analyzed at 6 wk after transplant for the presence of DCs in the lungs and
SDLNs, using antibodies specific for CD45.1 and CD45.2 to identify the
donor cell of origin.
SeV infection. Sendai/52 virus (Fushimi strain) was purchased from the
American Type Culture Collection and subjected to two rounds of in vitro
plaque purification on Vero E6 cells. Afterward, a single clone was subjected
to a round of amplification in embryonated chicken eggs. SeV was isolated
from the allantoic fluid and diluted in PBS to generate a viral stock. Calculation of plaque-forming units was performed by standard plaque assay using
either Vero E6 or LLC-MK2 cells. Mice were infected with 100 PFU of
virus instilled intranasally. Mice were weighed at baseline and daily for 19 d.
At the time points indicated in the figures, lungs were harvested and portions
were fixed for histology. Remaining portions were digested for leukocyte
preparation, and cells were stained and assayed by flow cytometry.
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Antibodies and flow cytometry. Staining was performed at 4°C in the
presence of Fc Block (clone 2.4G2; BD) in FACS buffer (Dulbecco’s PBS
[DPBS] + 0.5% BSA + 2 mm EDTA + 0.02% sodium azide). The following
antibodies and secondary reagents were purchased from BD: biotin–anti–c-Kit
(2B8), biotin–anti-CD3e (2C11), FITC–anti-CD3e (2C11), FITC–anti-Mac3
(M3/84), FITC–anti-Ly6C (AL-21), FITC–anti-B220 (RA3-6B2), FITC–
anti–I-Ab (25-9-17), FITC–anti-Gr1 (RB6-8C5), PE–anti-Flt3 (A2F10.1),
PE–anti–LPAM-1 (47 integrin, DATK32), PE–anti-CD43 (S7), PE–anti–
I-Ab (AF6-120.1), PE–anti-CD11c (HL3), PE– and PE-Cy7–anti-CD11b
(M1/70), PE-Cy7–anti-CD4 (RM4-5), PE-Cy7–anti-CD8 (53-6.7),
PerCP Cy5.5–anti-CD45.1 (A20), allophycocyanin–anti-SIRP (P84),
allophycocyanin–anti-CD8 (53-6.7), Alexa Fluor 700–anti-CD45.2 (104),
streptavidin-PerCP, streptavidin–PE-Cy7, and streptavidin-allophycocyanin.
The following antibodies and secondary reagents were purchased form
eBioscience: biotin–anti-B220 (RA3-6B2), biotin–anti-CD49b (DX5), biotin–
anti–Thy-1.2 (53-2.1), biotin–anti-Ter119 (Ter119), biotin–anti-CD103
(2E7), FITC–anti-CD19 (ebio1D3), PE–anti-Flt3 (A2F10), PE–anti-CD103
(2E7), PE–anti-Foxp3 (FKJ-16s), PE-Cy7–anti–c-Kit (2B8), allophycocyanin–anti-CD115 (AFS98), allophycocyanin–anti-CD45.2 (104), allophycocyanin Alexa Fluor 750–anti-CD11c (N418), Alexa Fluor 700–anti–Sca-1
(D7), allophycocyanin Alexa Fluor 750–anti-CD8a (53-6.72), allophycocyanin eFluor 780–anti-CD11c (N418), and streptavidin–allophycocyanin eFluor
780. Alexa Fluor 488–anti-CD207/Langerin (929F3.01) was purchased
from Imgenex. FITC–anti-CD8 (5H10), FITC–anti-CD4 (CT-CD4),
allophycocyanin–anti-CD8 (5H10), and streptavidin–allophycocyanin-Cy7
were purchased from Invitrogen. Allophycocyanin–anti-CD205/DEC205
(NLDC-145) was purchased from Miltenyi Biotec. FITC–anti-CCR9 (242503)
was purchased from R&D Systems. The following antibodies were maintained as hybridomas, with purified antibody conjugated to Pacific blue
succinimidyl ester (Invitrogen): anti-CD11b (M1/70), anti-B220 (6B2),
anti-Gr1 (RB6-8C5), anti-Ter119 (Ter119), anti-CD3e (2C11), anti-CD4
(GK1.5), and anti-CD8 (53-6.7). Kb-SeV NP 324–332 (FAPGNYPAL)
MHC pentamers were purchased from Proimmune.
For lung DC staining, samples were fixed in 4% formaldehyde for 15 min
at room temperature after surface antibody staining and before use of streptavidin reagents. For all experiments involving intracellular anti-Langerin staining, cells were surface antibody stained before fixation in 4% formaldehyde
for 15 min at room temperature. Cells were subsequently permeabilized
(DPBS + 0.1% BSA + 0.5% saponin) for 5 min at 4°C and stained in the same
buffer with anti-Langerin and steptavidin reagents. Cells were washed twice
in permeabilization buffer before returning them to FACS buffer. For intracellular Foxp3 staining, cells were fixed and permeabilized with buffers purchased as part of the Foxp3 staining buffer set (eBioscience). Flow cytometry
was performed on a FACSCalibur, FACSCanto II, or LSR II (BD).

(5-mM final concentration) was added to cell suspensions, and cells were
incubated on ice for 5 min. Cells were passed through a 40-µm strainer before
red blood cells lysis with ACK lysis buffer. Cells were counted on a Vi-CELL
analyzer, and 2–3 × 106 cells were used per antibody staining reaction.
Small intestinal LP cells were prepared from dissected small intestines
after removal of Peyer’s patches and residual fat. Small (5-mm) pieces
of opened intestine were washed well in DPBS, incubated in 40 ml
cIMDM for 45 min at 37°C with shaking at 250 rpm, vortexed, and
washed again in cIMDM. Pieces were digested in 30 ml cIMDM with
250 µg/ml collagenase B and 30 U/ml DNase I for 1 h at 37°C with stirring. Cells were passed through a 40-µm strainer before resuspension in
4 ml of 40% Percoll (Sigma-Aldrich). This suspension was overlaid with
4 ml of 70% Percoll and centrifuged at room temperature for 20 min at
900 g without braking. Cells were collected from the interface, washed
with buffer (DPBS + 3% FCS + 0.02% sodium azide), counted, and
stained for flow cytometry.
Dermal and epidermal cell suspensions were prepared from mouse ear
skin. Dorsal and ventral ear flaps were teased apart with gentle traction, and
individual flaps were digested in 3 ml cIMDM with 2 mg/ml Dispase II
(Roche) for 2.5 h at 37°C with slow rotation in 6-well plates. Epidermal sheets
generally “floated” off of the underlying dermis, although in some cases forceps were used to fully separate the skin layers. Epidermal and dermal sheets
were separately digested in a fashion identical to that described for lymph
nodes to result in cell suspensions for antibody staining and flow cytometry.
Monocytes, pre-cDCs, and mature cDCs were isolated on a cell sorter
(MoFlo; Dako). BM monocytes were identified as CD11b+Ly6Chigh cells,
excluding CD11b+Ly6Cint neutrophils. Pre-cDCs from BM and spleen were
identified as CD11c+CD43+SirpintI-AbCD11bB220Gr1CD4CD8
cells after enrichment of CD11c+ cells by magnetic bead–based positive selection with anti-CD11c beads (Miltenyi Biotec). Mature cDCs from spleens
were identified as either CD11c+CD8+DEC205+CD4CD11bB220
DX5Thy1.2Gr1Ter119 or CD11c+CD4+CD11b+CD8DEC205
B220DX5Thy1.2Gr1Ter119 cells after enrichment of CD11c+ cells by
magnetic bead–based positive selection using anti-CD11c beads. RNA from
these sorted cell populations was purified using RNeasy kits (QIAGEN).
CDPs from BM were isolated on a cell sorter (FACSAria II; BD) as
c-KitintSca-1Flt3+CD115+CD11bCD11cB220Gr1Ter119CD3CD4
CD8 cells. Cells were sorted directly into 1 ml of TRIzol reagent (Invitrogen),
and 25 µl of linear acrylamide (Applied Biosystems) was added as a coprecipitant. The aqueous phase was extracted with chloroform, and RNA was precipitated with 2-propanol, washed once with 75% ethanol, and resuspended in
RNase-free water before quantitative real-time RT-PCR analysis.
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DSS-induced colitis. Mice were allowed free access to filtered drinking
water containing 5% DSS (TDB Consultancy). Mice were weighed at baseline
and daily for 1 wk.

Histology. Small pieces of lung, small intestine, colon, and ear were fixed
in 10% buffered formalin and embedded in paraffin. 5-µm sections were
stained with hematoxylin and eosin (H&E). For analysis of intestinal histology in the experiment involving DSS treatment, small intestines, cecums,
and colons were harvested on day 7 and fixed in Bouin’s fixative and pinned
on black wax for 3 h at 4°C. After washing with 70% ethanol, strips of tissue were embedded in 2% agar for routine paraffin processing, cut in serial
sections, and stained with H&E. Morphometric analysis was performed on
the distal rectum of these mice. Areas of atrophic crypts were defined as
those with <20 epithelial cells observed on cross section through welloriented crypts, with no cells in M phase present. Areas of intact crypts
were defined as those with >30 epithelial cells observed on cross section
through well-oriented crypts, with cells in M phase present.
Expression microarray analysis. Expression microarrays (available from
the Gene Expression Omnibus under accession no. GSE17322) for lung DC
subsets were originally published in Sung et al. (2006). Expression micro
arrays (available from the Gene Expression Omnibus under accession no.
GSE6259) for splenic cDC subsets were originally published in Dudziak et al.
(2007). Data were normalized and expression values were modeled using
DNA-Chip Analyzer software (dChip; Li and Wong, 2001a,b).
Quantitative RT-PCR. cDNA was prepared using SuperScript III reverse
transcriptase (Invitrogen). For real-time PCR, the relative standard curve
method, SYBR Green PCR Master Mix, and a StepOnePlus Real-Time
PCR System (Applied Biosystems) were used according to the manufacturer’s instructions. PCR conditions were 1 min at 95°C, followed by 45
two-step cycles consisting of 15 s at 95°C and 1 min at 50°C, followed
by a melting curve analysis to determine product purity. The values were
normalized to that of Hprt1 by dividing the mean copy number of the
respective transcript sample. Primers used were as follows: Batf3 forward,
5-CAGACCCAGAAGGCTGACAAG-3; Batf3 reverse, 5-CTGCGCAGCACAGAGTTCTC-3; Irf8 forward, 5-TGCCACTGGTGACCGGATAT-3; Irf8 reverse, 5-GACCATCTGGGAGAAAGCTGAA-3;
Hprt1 forward, 5-TCAGTCAACGGGGGACATAAA-3; and Hprt1
reverse, 5-GGGGCTGTACTGCTTAACCAG-3.
Statistical analysis. Differences between groups were analyzed by an
unpaired, two-tailed Student’s t test, with P ≤ 0.05 considered significant
(Prism; GraphPad Software, Inc.).
Online supplemental material. Fig. S1 demonstrates that the defect in
the development of peripheral CD103+CD11b DCs is cell intrinsic in
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CHS. Three separate protocols were used for CHS. A 2 × 2 cm area of
abdominal skin was shaved in those groups of mice receiving sensitization.
Control mice received no treatment to their abdomens. Sensitization in our
basic protocol (Fig. 6; and Fig. S6, protocol A) involved two applications of
50 µl of 0.5% DNFB (Fluka) in a 1:4 olive oil/acetone solution on days 5
and 4. Protocol B differed from protocol A in that only a single sensitizing
dose was applied to the abdomen at day 5. Protocol C (a “low-dose” protocol, similar to that used in Bursch et al. [2007] and Wang et al. [2008])
involved only a single sensitizing dose of 25 µl of 0.3% DNFB in a 1:4 olive
oil/acetone solution on day 5. In Protocols A and B, elicitation of CHS
was performed on day 0 by the application of 20 µl of 0.2% DNFB in a 1:4
olive oil/acetone solution to each ear after measurement of baseline thickness with a micrometer. In Protocol C, elicitation was performed on day 0
by the application of 10 µl of 0.15% DNFB in a 1:4 olive oil/acetone solution to each ear after measurement of baseline thickness. Ears were measured on days 1–3, and ear swelling was calculated as the difference between
baseline ear thickness and the measured value.

Batf3/ mice. Fig. S2 demonstrates increased weight loss and pulmonary
inflammation in Batf3/ mice infected with SeV. Fig. S3 shows an analysis
of DCs and T reg cells from the MLNs of Batf3/ mice. Fig. S4 shows an
analysis of homing receptor expression on intestinal T cells from Batf3/
mice. Fig. S5 demonstrates normal sensitivity to DSS-induced colitis in
Batf3/ mice. Fig. S6 tests alternative protocols for the induction of CHS.
Fig. S7 shows an analysis of pre-cDCs from Batf3/ mice, and shows quantitative RT-PCR data for the expression of Batf3 and Irf8 in developing and
mature DC populations. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20091627/DC1.
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